Inhalants: not to be taken lightly anymore

Current Opinion in Psychiatry
Ty A Ridenour

Abstract

Until recently, inhalant abuse and dependence have been overlooked as serious problems, perhaps because of their relatively low prevalence. The purpose of this review is to summarize recent advances in our understanding of the consequences, pharmacology, and etiology of inhalant use, and how we might develop preventive and management strategies to combat abuse and dependence on these drugs. Animal models have cast light on how reinforcement of inhalant use occurs, and on mechanisms of development of tolerance and dependence. The reinforcing effects occur principally through GABA and dopamine-mediated mechanisms (rather than NMDA-mediated mechanisms). Assays for inhalants provide greater opportunities for accurate diagnosis. In addition to known medical consequences of inhalant use (including death), other risks associated with inhalant use and addiction include addiction to other substances, major depression, suicide, and impaired learning and memory. The extensive medical, psychiatric, and psychological damage that can be caused by inhalant use argues for much greater attention to be paid to developing prevention and treatment programmes for inhalant abuse and dependence. These are currently nonexistent, but are badly needed.

References

Jun 1, 1987·American Journal of Epidemiology·A R MossJ Carlson
May 1, 1997·Pharmacology, Biochemistry, and Behavior·S E Bowen, R L Balster
Aug 26, 1998·Drug and Alcohol Dependence·R L Balster
Feb 27, 1999·Toxicology Letters·L S Soderberg
Apr 6, 1999·Addictive Behaviors·M O Howard, J M Jenson
Nov 5, 1999·The American Journal of Drug and Alcohol Abuse·E L McGarveyD Waite
Nov 9, 2000·The New England Journal of Medicine·J PaukL Corey
Feb 13, 2001·Drug and Alcohol Dependence·M O HowardA Ben-Abdallah
Apr 19, 2003·Drug and Alcohol Dependence·Gregory F LopreatoS John Mihic
Apr 23, 2003·Life Sciences·Jenny L WileyRobert L Balster
May 23, 2003·The New England Journal of Medicine·Jason A CampagnaStuart A Forman
Jun 13, 2003·Substance Use & Misuse·Beatriz Carlini-MarlattMaria de Fátima Marinho Souza
Sep 27, 2003·European Journal of Pharmacology·Madina R GerasimovRobert L Balster
Nov 14, 2003·Toxicology and Applied Pharmacology·Nayeli Páez-MartínezCarolina López-Rubalcava
Dec 13, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ibrahim A WasfiNawal Abdulla Al Katheeri
Jan 9, 2004·Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53·Judy A AndrewsHerbert H Severson
Jan 17, 2004·Drug and Alcohol Dependence·C Debra M Furr-HoldenSheppard G Kellam
Feb 6, 2004·European Journal of Pharmacology·Elena A BlokhinaEdwin E Zvartau
Apr 2, 2004·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Maristela FerigoloHelena Maria Tannhauser Barros
Aug 24, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Joseph T SakaiThomas J Crowley
Sep 24, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Li-Tzy WuWilliam E Schlenger
Sep 24, 2004·Suicide & Life-threatening Behavior·Paul S F YipSusan Fan
Oct 19, 2004·Drug and Alcohol Dependence·Diana J WalkerJames P Zacny
Oct 27, 2004·Pharmacology, Biochemistry, and Behavior·Keith L Shelton, Robert L Balster

❮ Previous
Next ❯

Citations

Aug 26, 2010·Journal of Ethnicity in Substance Abuse·Carlos ZubaranWagner Homero
Nov 16, 2006·PLoS Medicine·Christian Lüscher, Mark A Ungless
Jul 16, 2013·Revista da Associação Médica Brasileira·Carlos ZubaranPaulo Roberto Franceschini
Jan 1, 2012·Journal of Drug Education·Stephen R Shamblen, Ted Miller
Dec 19, 2008·Drug and Alcohol Dependence·Brian E PerronMichael G Vaughn
Jul 13, 2007·Drug and Alcohol Dependence·Michael G VaughnMatthew O Howard
Jun 20, 2007·Drug and Alcohol Dependence·Ty A RidenourLinda B Cottler
Apr 17, 2007·Drug and Alcohol Dependence·Stacey FreedenthalMatthew O Howard
Nov 1, 2006·Drug and Alcohol Dependence·Krista Lisdahl Medina, Paula K Shear
Mar 10, 2016·Journal of Pharmacy & Bioallied Sciences·Raka Jain, Arpita Verma
Apr 24, 2017·Neurotoxicology and Teratology·Sergio MontesNayeli Páez-Martínez
Apr 10, 2014·Ciência & saúde coletiva·Fernando Silva-OliveiraPatrícia Maria Zarzar
Nov 20, 2013·Substance Abuse : Research and Treatment·Brogen Singh AkoijamGojendra Singh Senjam

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Child and Adolescent Psychiatry
Joseph T SakaiThomas J Crowley
Current Opinion in Psychiatry
María Elena Medina-Mora, Tania Real
Drug and Alcohol Dependence
R L Balster
Neuroscience and Biobehavioral Reviews
E B Evans, R L Balster
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
G K Aghajanian, G J Marek
© 2022 Meta ULC. All rights reserved